Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’ – Financial Express
|
Stempeutics receives Japan process patent for its stem cell drug 'Stempeucel'
Financial Express Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, has been granted process patent from the Japan Patent Office (application no 2012-540529) for its novel stem–cell based drug … Stempeutics receives Japan process patent for its novel stem cell drug … Stempeutics receives ODD in EU for its novel stem cell drug “Stempeucel” Stempeutics gets process patent for Stempeucel from Japan |
